Waystar reported robust third-quarter results with a 12% year-over-year revenue growth to $269 million, bolstered by successful client retention strategies and the recent acquisition of Iodine Software.
- Achieved an adjusted EBITDA margin of 42%, exceeding growth expectations.
- Completed the acquisition of Iodine Software, expanding total addressable market by over 15% and enhancing product capabilities.
- Successfully hosted Waystar True North conference, demonstrating significant client ROI through improved operational efficiencies and revenue capture.
- Continued strengthening of market position with integration capabilities across over 500 electronic health records and practice management systems.
Community Discussion